The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health”(Coach) Program in Type 2 Diabetes in Tasmania.

AJ Palmer, Margarite J. Vale, CL Wells, Chantal Ski, David Thompson, L Si

Research output: Contribution to journalMeeting abstractpeer-review

Abstract

Objectives: The “Coaching patients On Achieving Cardiovascular Health”
(COACH) Program is a structured telephone and mail-out delivered program that
trains people with chronic diseases including type 2 diabetes to achieve guideline recommended target levels for their cardiovascular risk factors while working with their usual medical practitioners. Our aim was to evaluate the long-term cost-effectiveness of this innovative patient education program in type 2 diabetes patients in Tasmania.
Methods: Baseline cohort characteristics and treatment
effects were derived from data collected by Diabetes Tasmania in a real life setting at baseline (N=975) and 18 months after a 6-month COACH Program training period. A published and validated simulation model of diabetes (IMS-CORE Diabetes Model) projected 24-month improvements in glycemic control, blood pressure and lipids to quality-adjusted life years (QALYs) and total lifetime direct costs in type 2 diabetes patients with The COACH Program+usual care versus usual care alone. Australian-specific complication costs were taken from published sources. The costs of The COACH Program were included. Analyses were run over patient lifetimes and were performed from a third-party payer perspective. Future costs and QALYs gained were discounted at 5% per annum. Probabilistic sensitivity analysis was performed. Results: The COACH Program cost AUD1,296/patient to implement. After 6 months, HbA1c improved by mean (standard deviation) 0.35%-points (1.00%-points) from baseline of 7.15% (1.50%), and had a positive effect on lipid profile, BMI and blood pressure, translating into reduced risks of micro- and macrovascular complications, and increased QALYs of mean (95%CI) 0.058(0.023-0.092) years and increased costs of AUD 215(-902 to 1,333) per patient versus usual care alone, with an incremental cost-effectiveness ratio of AUD3,737/ QALY gained.
Conclusions: Long-term projections indicated that improved glycemic control, blood pressure and lipid profile sustained over an 18 month period following the 6 month COACH Program is highly cost effective in Type 2 diabetes patients in Tasmania.
Original languageEnglish
Pages (from-to)A899-A899
Number of pages1
JournalValue in Health
Volume19
Issue number7
Publication statusPublished - 01 Nov 2016

Fingerprint Dive into the research topics of 'The Longterm Cost Effectiveness of the “Coaching Patients on Achieving Cardiovascular Health”(Coach) Program in Type 2 Diabetes in Tasmania.'. Together they form a unique fingerprint.

Cite this